TW212138B - - Google Patents

Download PDF

Info

Publication number
TW212138B
TW212138B TW78109649A TW78109649A TW212138B TW 212138 B TW212138 B TW 212138B TW 78109649 A TW78109649 A TW 78109649A TW 78109649 A TW78109649 A TW 78109649A TW 212138 B TW212138 B TW 212138B
Authority
TW
Taiwan
Prior art keywords
nucleus
degassed
guano
pharmaceutical composition
amino
Prior art date
Application number
TW78109649A
Other languages
English (en)
Chinese (zh)
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Application granted granted Critical
Publication of TW212138B publication Critical patent/TW212138B/zh

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
TW78109649A 1988-12-14 1989-12-13 TW212138B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US28415388A 1988-12-14 1988-12-14

Publications (1)

Publication Number Publication Date
TW212138B true TW212138B (de) 1993-09-01

Family

ID=23089064

Family Applications (1)

Application Number Title Priority Date Filing Date
TW78109649A TW212138B (de) 1988-12-14 1989-12-13

Country Status (2)

Country Link
TW (1) TW212138B (de)
ZA (1) ZA899510B (de)

Also Published As

Publication number Publication date
ZA899510B (en) 1990-08-29

Similar Documents

Publication Publication Date Title
US11266666B2 (en) Methods for treating Filoviridae virus infections
US4861759A (en) Antiviral compositions and methods
EP1395266B1 (de) Verwendungen von antiviralen nucleosid-derivaten zur herstellung eines medikaments zur behandlung von hepatitis c infektionen
JP2011032281A (ja) 抗ガン剤及びｄｎａ複製阻害剤
DK169657B1 (da) Anvendelse af visse uracilnucleosider til fremstilling af et lægemiddel mod adenovirusinfektioner samt oftalmiske præparater indeholdende sådanne uracilnucleosider
JPS63239294A (ja) 新規アデノシン誘導体及び該化合物を有効成分として含有する医薬組成物
JPS63290895A (ja) 抗ウイルスヌクレオシド
TW469132B (en) Antiviral combinations
JPH03167197A (ja) 治療的ヌクレオシド
US5616566A (en) Method of inhibiting HIV replication with 2',3'-dideoxyadenosine
AU628113B2 (en) 2',3'-dideoxypurine nucleoside/purine nucleoside phosphorylase inhibitor combination therapy and composition
CA2085367A1 (en) Hiv-transactivators to treat aids
TW212138B (de)
Polmar Enzyme replacement and other biochemical approaches to the therapy of adenosine deaminase deficiency
PT99434A (pt) Processo para a preparacao de composicoes farmaceuticas contendo derivados de xantina
AU5832990A (en) Method of treatment of hepatitis
JPH03264530A (ja) 抗レトロウイルス剤
CN107540631A (zh) 氨基羧酸酯类化合物在治疗寨卡病毒感染方面的应用
NZ754996B2 (en) Nucleotide hemi-sulfate salt for the treatment of hepatitis c virus
NZ754996A (en) Nucleotide hemi-sulfate salt for the treatment of hepatitis c virus
US20130059812A1 (en) Composition for treating chronic hepatitis b, containing clevudine and adefovir dipivoxil
JPH02164822A (ja) （ｈ↑＋＋ｋ↑＋）―アデノシントリホスファターゼ阻害剤
CA1333392C (en) Antiviral compounds
JPH0544925B2 (de)
JPS63267727A (ja) Ｓ−ラクトイルグルタチオンおよび／またはその塩を有効成分とする医薬